Immunomodulation for prion and prion-related diseases

Area of Science:

• Neuroscience
• Immunology
• Infectious Diseases

Background:

• Prion diseases are fatal neurodegenerative disorders caused by misfolded prion proteins (PrPSc).
• Current treatments are ineffective, necessitating the development of novel prophylactic and therapeutic strategies.
• Conformational disorders like Alzheimer's disease share similarities, suggesting shared therapeutic targets.

Purpose of the Study:

• To investigate the potential of mucosal immunization as a safe and effective strategy against prion diseases.
• To explore the feasibility of using an attenuated Salmonella vaccine strain for prion protein delivery.
• To assess the ability of mucosal vaccination to prevent prion infection and associated pathology.

Main Methods:

• Development of an attenuated Salmonella vaccine strain engineered to express prion protein.
• Administration of the modified vaccine via mucosal immunization in a relevant animal model.
• Evaluation of the immune response and protection against peripheral prion infection.

Main Results:

• Mucosal vaccination with the engineered Salmonella strain demonstrated protection against prion infection from a peripheral source.
• This approach induced a localized immune response, potentially preventing prion entry via the alimentary tract.
• The study suggests that mucosal immunization can elicit a modulated systemic immunity with reduced risk of autoimmune toxicity.

Conclusions:

• Mucosal immunization represents a feasible and promising approach for preventing prion diseases.
• This strategy may offer a safer alternative to systemic immunization, balancing efficacy with reduced autoimmune risks.
• Further development of immunomodulatory approaches targeting prion protein or shared pathological conformers could impact various age-associated dementias.